—
Enter label dose
Trial reference
From your label
Enter your label dose — the gauge updates instantly.
300 mg elemental per day compared citrate, amino-acid chelate and oxide in healthy adults. The endpoint was absorption (urinary, serum, salivary magnesium), not a symptom — oxide did not separate from placebo.
Educational only — not medical advice. Disclaimer.
NIH DSLD market slice
Bulk CSV dump 16 January 2026 · label entries through 2025. Disclosed amounts only — proprietary blends without gram weights excluded.
Trial floors
Primary
Form-comparison trial (elemental) · 300 mg over 60 days · Benefit shown — 300 mg elemental per day compared citrate, amino-acid chelate and oxide in healthy adults. The endpoint was absorption (urinary, serum, salivary magnesium), not a symptom — oxide did not separate from placebo.
Other floors
Daily value (women) · 320 mg — FDA daily value reference — not a trial dose.
Daily value (men) · 420 mg — FDA daily value reference — not a trial dose.
Bisglycinate sleep trial (elemental) · 250 mg over 4 weeks · Benefit shown — 250 mg elemental as bisglycinate beat placebo on Insomnia Severity Index at week 4, but the effect was small (Cohen's d = 0.2) and concentrated in people with low dietary magnesium intake.
Label reading notes
- Labels may list compound weight (glycinate, citrate, oxide) — convert to elemental magnesium before comparing to trial floors or the FDA daily value.
- Use the magnesium elemental calculator when the label quotes the salt, not elemental milligrams.
- Oxide, citrate, and glycinate behaved differently in absorption trials; a high compound weight on oxide often delivers modest elemental magnesium and more laxative effect.
- Sleep and "calm" blends may bury magnesium inside a multi-ingredient matrix — isolate elemental dose before judging whether you reached a studied repletion range.


